Opiant Pharmaceuticals (OPNT) Stock Price, News & Analysis
Price Move History
- Daily moves over 5%
- 41 252 sessions, March 1, 2022 to March 1, 2023
- Largest daily move
- +111.6% close of November 14, 2022
- 1-year change
- -28.8% closing prices, March 1, 2022 to March 1, 2023
- 1-month change
- +3.1% closing prices, February 1, 2023 to March 1, 2023
Company Description
Opiant Pharmaceuticals (NASDAQ: OPNT) is classified in the biotechnology industry within the Healthcare sector.
OPNT has declined 28.8% over the past year. The last closing price was $20.65.
This page collects what Stock Titan holds for OPNT, including price data and latest news.
Stock Performance
Opiant Pharmaceuticals (OPNT) closed at $20.65 on March 1, 2023. Over the past 12 months, the price has lost 28.8%.
OPNT Metrics & Rankings
Price returns through March 1, 2023. Month-to-date and YTD include the first trading day. Ranking links may use different dates.
Latest News
Opiant Pharmaceuticals has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include acquisition, clinical trial, fda approval, earnings, conferences. View all OPNT news →
SEC Filings
OPNT Company Profile & Sector Positioning
Opiant Pharmaceuticals (OPNT) operates in the Biotechnology industry within the broader Healthcare sector and is listed on the NASDAQ.
Investors comparing OPNT often look at related companies in the same sector, including Fortress Biotech, Inc. (FBIO), Zentalis Pharmaceuticals, Inc. (ZNTL), Adagene Inc. (ADAG), Spero Therapeutics, Inc. (SPRO), and Vistagen Therapeutics, Inc. (VTGN). Comparing financial metrics, valuation ratios, and stock performance across these peers can help investors evaluate OPNT's relative position within its industry.